Cannabis consumption and mental disease: the hen or egg question in a disastrous relationship
- Symposien
- Berlin
- Datum
- Ort Berlin
Weitere Informationen
Cannabis consumption around puberty has long been discussed as an inducer drug of schizophrenia or, alternatively, as desperate self-medication during psychotic episodes or during the disease prodrome. Nowadays, it is quite safe to say that despite some truth to both views, cannabis can induce schizophrenia in predisposed individuals, dose-dependently lead to earlier disease onset, and act as trigger of psychotic relapses. But it can also result in amotivational behavior, social withdrawal or cognitive deficits upon peripubertal use. Here, a specific and highly relevant responsibility of psychiatry arises, and awareness among essentially all clinicians and in the general public needs to grow. Legalizing cannabis may not send the right message to the public.
PROGRAMME
Cannabis and psychosis: news from a long-term relationship
Robin Murray | United Kingdom
How does cannabis work: understanding basics of the brain cannabinoid system
Prof. Dr. Beat Lutz | Germany
Juvenile cannabis consumption as risk factor of behavioural abnormalities and mental illness
Prof. Dr. Dr. Hannelore Ehrenreich ML | Germany
Cannabis use and its consequences after its legal release
William G. Honer | Canada
ML – Member of the Leopoldina
Picture: Holger Schwarz
Weitere Informationen
Es handelt sich um eine geschlossene Veranstaltung für Fachpublikum. Eine Anmeldung ist erforderlich (Kongressanmeldung).
Kontakt
Slava Platikanova
DGPPN e. V.
Tel.: (030) 2404772-13
E-Mail: s.platikanova(at)dgppn.de